Familial testicular cancer: Interest in genetic testing among high-risk family members

Genetics in Medicine

Volumn 8, Issue 12, 2006, Pages 760-770

  Peters, June A ^a   Vadaparampil, Susan T ^b   Kramer, Joan ^a   Moser, Richard P ^a   Court, Lori Jo Peterson ^a,c   Loud, Jennifer ^a   Greene, Mark H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Caldera Pharmaceuticals   (United States)

Author keywords

Familial; Genetic testing; Psychosocial; Social support; Testicular cancer

Indexed keywords

ADULT; ARTICLE; CANCER RISK; COVARIANCE; DEMOGRAPHY; DISTRESS SYNDROME; FAMILIAL CANCER; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEALTH BELIEF; HIGH RISK POPULATION; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PSYCHOLOGICAL ASPECT; SOCIAL ASPECT; TESTIS CANCER;

EID: 33845758875     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gim.0000250506.15979.0c     Document Type: Article

References (97)

1. Edwards BK, Brown ML, Wingo PA, Howe HL, et al. Annual Report to the Nation on the Status of Cancer, 1975-2002, Featuring Population-Based Trends in Cancer Treatment. JNCI Cancer Spectrum 2005;97:1407-1427.
2. Al Tourah AJ, Murray N, Coppin C, Kollmannsberger C, et al. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: A population based analysis from British Columbia. Urology 2005;174:2209-2213.
3. Bloom JR, Fobair P, Gritz E, Wellisch D, et al. Psychosocial outcomes of cancer: A comparative analysis of Hodgkin's disease and testicular cancer. J Clin Oncol 1993;11:979-988.
4. Sirohi B, Huddart R. The management of poor-prognosis, non-seminomatous germ-cell tumours. Clinical Oncology 2005;17:543-552.
5. Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA, et al. International patterns and trends in testis cancer incidence. Int J Cancer 2005;115:822-827.
6. Kramer JL, Greene MH. Hereditary Testicular Cancer. In: Vogelzang N, Scardino P, Shipley W, Debruyne F, Linehan WM, editors. Comprehensive Textbook of Genitoruinary Oncology. 3rd ed. Philadelphia: Lippincott; 2006, pp 558-562.
7. Dieckmann K, Pichlmeier U. The prevalence of familial testicular cancer: an anlysis of two patient populations and a review of the literature. Cancer 1997;80:1954-1960.
8. Hemminki K, Li XJ, Czene K. Familial risk of cancer: Data for clinical counseling and cancer genetics. International Journal of Cancer 2004;108:109-114.
9. Holzik ML, Rapley EA, Hoekstra HJ, Sleijfer DT, et al. Genetic predisposition to testicular germ-cell tumours. The Lancet Oncology 2004;5:363-371.
10. Bishop DT, Rapley E, Crockford G, Biggs P, et al. Candidate regions for testicular cancer susceptibility genes: The results of two genomic searches. Am J Hum Genet 1997;61:A268.
11. Heimdal K, Olsson H, Tretli S, Fossa SD, et al. A segregation analysis of testicular cancer based on Norwegian and Swedish families. Brit J Cancer 1997;75:1084-1087.
12. Rapley E, Tucker K, Collins F, Donald J, et al. Candidate regions for testicular cancer susceptibility genes. APMIS 1998;106:64-70.
13. Rapley EA, Crockford GP, Teare D, Biggs P, et al. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet 2000;24:197-200.
14. Rapley EA, Crockford GP, Easton DF, Stratton MR, et al. Localisation of susceptibility genes for familial testicular germ cell tumour. APMIS 2003;111:128-135.
15. Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, et al. The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet 2005;77:1034-1043.
16. Crockford GP, Linger R, Hockley S, Dudakia D, et al. Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Human Molecular Genetics 2006;15:443-451.
17. Bratt O, Kristoffersson U, Lundgren R, Olsson H, et al. Sons of men with prostate cancer: Their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Urology 1997;50:360-365.
18. Bratt O, Damber J-E, Emanuelsson M, Kristoffersson U, et al. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 2000;36:235-241.
19. Diefenbach MA, Schnoll RA, Miller SM, Brower L, et al. Genetic testing for prostate cancer - Willingness and predictors of interest. Cancer Practice 2000;8:82-86.
20. Doukas DF, Fetters MD, Coyne JC, McCullough LB, et al. How men view genetic testing for prostate cancer risk: findings from focus groups. Clin Genet 2000;58:169-176.
21. Xu JF, Dimitrov L, Chang BL, Adams TS, et al. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 2005;77:219-229.
22. Burke W, Zimmern RL. Science and society - Ensuring the appropriate use of genetic tests. Nat Rev Genet 2004;5:955-959.
23. Struewing JP, Lerman C, Kase RG, Giambarresi TR, et al. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 1995;4:169-731.
24. Andrykowski MA, Lightner R, Studts JL, Munn RK, et al. Hereditary cancer risk notification and testing: how interested is the general population? J Clin Oncol 1997;15:2139-2148.
25. Vernon SW, Gritz ER, Peterson SK, Perz CA, et al. Intention to learn results of genetic testing for hereditary colon cancer. Cancer Epidemiol Biomarkers Prev 1999;8:353-360.
26. Gamm JL, Nussbaum RL, Biesecker BB. Genetics and alcoholism among at-risk relatives II: Interest and concerns about hypothetical genetic testing for alcoholism risk. Am J Med Genet 2004;128:A151-A155.
27. Sanderson SC, Wardle J, Jarvis MJ, Humphries SE, et al. Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK. Prevent Med 2004;39:458-464.
28. Lerman C, Daly M, Masny A, Balshem A, et al. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994;12:843-850.
29. Hughes C, Gomez-Caminero A, Benkendorf J, Kerner J, et al. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 1997 September;32:51-62.
30. Biesecker BB, Ishibe N, Hadley DW, Giambarresi TR, et al. Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am J Med Genet 2000;93:257-263.
31. Greene MH. Cancer families: A resource for etiologic studies. In: Castellani A, editor. Epidemiology and Quantitation of Environmental Risks in Humans from Radiation and Other Agents- Potential and Limitations. New York: Plenum Press; 1985: pp 213-223.
32. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Education Quarterly 1988;15:175-183.
33. Armstrong K, Weiner J, Weber B, Asch DA. Early adoption of BRCA1/2 testing: Who and why. Genet Med 2003;5:92-98.
34. Bowen DJ, Bourcier E, Press N, Lewis FM, et al. Effects of individual and family functioning on interest in genetic testing. Community Genetics 2004;7:25-32.
35. Kinney AY, Croyle RT, Bain C, Pelias MZ, et al. Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: A survey of a large African-American kindred with a BRCA1 mutation. J Law Medicine & Ethics 2001;29:47-48.
36. Vadaparampil ST , Azzarello L, Pickard J, Jacobsen PB. Intention to obtain genetic testing for melanoma among first degree relatives of melanoma patients. Am J Hematol 2006.
37. Kinney AY, Choi YA, DeVellis B, Kobetz E, et al. Interest in genetic testing among first-degree relatives of colorectal cancer patients. Am J Prevent Med 2000;18:249-252.
38. Press NA, Yasui Y, Reynolds S, Durfy SJ, et al. Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations. Am J Med Genet 2001;99:99-110.
39. Katz RC, Meyers K, Walls J. Cancer awareness and self-examination practices in young men and women. J Behav Med 1995;18:377-384.
40. Biesecker BB, McInerney A, Fost N, Green M, et al. Outcomes of a randomised trial on the use of a CD-ROM program on breast cancer genetics: Client knowledge, preferences and intent to undergo BRCA1/2 testing. J Med Genet 2000;37:6.
41. Glanz K, Grove J, Lerman C, Gotay C, et al. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiol Biomarkers Prev 1999;8:329-336.
42. Bluman LG, Rimer BK, Berry DA, Borstelmann N, et al. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol 1999;17:1040-1046, .
43. Rosenstock IM. Why people use health services. Milbank Mem Fund Q 1966;44 (Suppl):127.
44. Earp JA, Eng E, O'Malley MS, Altpeter M, et al. Increasing Use of Mammography Among Older, Rural African American Women: Results From a Community Trial. Am J Pub Health 2002;92:646-654.
45. Goldring AB, Taylor SE, Kemeny ME, Anton PA, et al. Impact of Health Beliefs, Quality of Life, and the Physician-Patient Relationship on the Treatment Intentions of Inflammatory Bowel Disease Patients. [Article]. Health Psychol 2002 May;21:219-228.
46. Hay JL, Ford JS, Klein D, Primavera LH, et al. Adherence to colorectal cancer screening in mammography-adherent older women. Health Psychol 2003;21:553-576.
47. rd ed. San Francisco: Jossey-Bass, 2002;45-66.
48. Champion VL, Scott CR. Reliability and validity of breast cancer screening belief scales in African American women. Nurs Res 1997;46:331-337.
49. Blesch KS. Health beliefs about testicular cancer and self-examination among professional men. Oncologist 1986;13:29-33.
50. Kinney AY, Croyle RT, Dudley WN, Bailey CA, et al. Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: A survey of a large African-American kindred with a BRCA1 mutation. Prevent Med 2001;33:543-551.
51. Schwartz MD, Lerman C, Brogan B, Peshkin BN, et al. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomarkers & Prevention 2005;14:1003-1007.
52. Audrain J, Schwartz MD, Lerman C, Hughes C, et al. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal. Ann Behav Med 1998;19:370-377.
53. Friedman LC, Webb JA, Richards CS, Plon SE, et al. Psychological and behavioral factors associated with colorectal cancer screening among Ashkenazim. Prev Med 1999;29:119-125.
54. Lerman C, Schwartz MD, Lin TH, Hughes C, et al. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 1997;65:414-420.
55. Lerman C, Rimer B, Trock B, Balshem A, et al. Factors associated with repeat adherence to breast cancer screening. Prev Med 1990;19:279-290.
56. Brain K, Norman P, Gray J, Rogers C, et al. A randomized trial of specialist genetic assessment: psychological impact on women at different levels of familial breast cancer risk. Brit J Cancer 2002;86:233-238.
57. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: A measure of subjective stress. Psychom Med 1979;41:209-218.
58. Vadaparampil ST, Ropka M, Stefanek ME. Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers. Familial Cancer 2005;4:195-206.
59. Derogatis L. Brief Symptom Inventory 18 (BSI 18) administration, scoring, and procedures manual. Minneapolis: National Computer Systems; 2001.
60. Peterson SK, Watts BG, Koehly LM, Vernon SW, et al. How families communicate about HNPCC genetic testing: Findings from a qualitative study. Am J Med Genet 2003 May 15;119:C78-C86.
61. Parkerson GR, Boradhead WE, Tse CK. Validation of the Duke Social Support and Stress Scale. Fam Med 1991;23:357-360.
62. Gritz ER, Peterson SK, Vernon SW, Marani SK, et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005;23:1902-1910.
63. Manne S, Audrain J, Schwartz M, Main D, et al. Associations between relationship support and psychological reactions of participants and partners to BRCA1 and BRCA2 testing in a clinic-based sample. Ann Behav Med 2004;28:211-225.
64. Peters JA, Kenen R, Giusti R, Loud J, et al. Exploratory study of the feasibility and utility of the colored eco-genetic relationship map (CEGRM) in women at high genetic risk of developing breast cancer. Am J Med Genet Part A 2004;130:A258-A264.
65. Lerman C, Schwartz MD, Miller SM, Daly M, et al. A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style. Health Psychol 1996;15:75-83.
66. Applebaum-Shapiro SE, Peters JA, O'Connell JA, Aston CE, et al. Motivations and concerns of patients with access to genetic testing for hereditary pancreatitis. Amer J Gastroenterol 2001;96:1610-1617.
67. Hadley DW, Jenkins J, Dimond E, Nakahara K, et al. Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med 2003;163:573-582.
68. Bratt OKU, Lunetta KL, Olsson H. Sons of men with prostate cancer: Their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Adult Urology 1997;50:360-365.
69. Bober SL, Hoke LA, Duda RB, Regan MM, et al. Decision-making about tamoxifen in women at high risk for breast cancer: Clinical and psychological factors. J Clin Oncol 2004;22:4951-4957.
70. Kim HL, Benson DA, Stern SD, Gerber GS, et al. Practice trends in the management of prostate disease by family practice physicians and general internists: An Internet-based survey. Urology 2002;59:266-271.
71. Plon SE, Peterson LE, Friedman LC, Richards CS, et al. Mammography behavior after receiving a negative BRCA1 mutation test result in the Ashkenazim: A community-based study. Genet Med 2000;2:307-311.
72. Pickles T. What's a man to do? Treatment options for localized prostate cancer. Can Fam Phys 2004;50:65-72.
73. Boulware LE, Meoni LA, Fink NE, Parekh RS, et al. Preferences, knowledge, communication and patient-physician discussion of living kidney transplantation in African American families. Am J Transplant 2005;5 (6):1503-12.
74. Braun KL, Fong M, Kaanoi ME, Kamaka ML, et al. Testing a culturally appropriate, theory-based intervention to improve colorectal cancer screening among Native Hawaiians. Prevent Med 2005;40:619-627.
75. Scheuner MT, Yoon PW, Khoury MJ. Contribution of mendelian disorders to common chronic disease: Opportunities for recognition, intervention, and prevention. Am J Med Genet Part C-Seminars in Medical Genetics 2004;125:C50-C65.
76. Wideroff L, Vadaparampil ST, Greene MH, Taplin S, et al. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet 2005;42:749-755.
77. Audrain J, Schwartz MD, Lerman C, Hughes C, et al. Psychological distress in women seeking genetic counseling for breast- ovarian cancer risk: the contributions of personality and appraisal. Ann Behav Med 1998;19:370-377.
78. Gwyn K, Vernon SW, Conoley PM. Intention to pursue genetic testing for breast cancer among women due for screening mammography. Cancer Epidemiol Biomarkers Prev 2003;12:96-102.
79. Vernon SW, Gritz ER, Peterson SK, Perz CA, et al. Intention to learn results of genetic testing for hereditary colon cancer. Cancer Epidemiol Biomarkers Prev 1999;8:353-360.
80. Bowen DJ, Burke W, McTiernan A, Yasui Y, et al. Breast cancer risk counseling improves women's functioning. Patient Educ Couns 2004;53 (1):79-86.
81. Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, et al. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev 1999;8:369-375.
82. Foster C, Evans DGR, Eeles R, Eccles D, et al. Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: Attributes, cancer worry, and barriers to testing in a multicenter clinical cohort. Genet Test 2004;8 (1):23-9.
83. Cutler SJ, Hodgson LG. To test or not to test: interest in Genet Test for Alzheimer's disease among middle-aged adults. American Journal of Alzheimer's Disease and Other Dementias 2003;18:9-20.
84. Doukas DJ. Genetics providers and the family covenant: Connecting individuals with their families. Genet Test 2003;7:315-321.
85. Hall MA, Rich SS. Patients' fear of genetic discrimination by health insurers: the impact of legal protections. Genet Med 2000;2:214-221.
86. Greely HT. Banning genetic discrimination. N Engl J Med 2005;353:865-867.
87. Bottorff JL, Ratner PA, Balneaves LG, Richardson CG, et al. Women's interest in Genet Test for breast cancer risk: The influence of sociodemographics and knowledge. Cancer Epidemiol Biomarkers Prev 2002;11:89-95.
88. Kash KM, Dabney MR. Psychological aspects of cancer screening in high-risk populations. Med Pediatr Oncol 2001;36:519-524.
89. Lerman C, Narod S, Schulman K, Hughes C, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes [see comments]. JAMA 1996;275:1885-1892.
90. Lerman C, Seay J, Balshem A, Audrain J, et al. Interest in Genet Test among firstdegree relatives of breast cancer patients. Am J Med Genet 1995;57:385-392.
91. Lipkus IM, Iden D, Terrenoire J, Feaganes JR, et al. Relationships among Breast Cancer Concern, Risk Perceptions, and Interest in Genet Test for Breast Cancer Susceptibility among African-American Women with and without a Family History of Breast Cancer. Cancer Epidemiol Biomarkers Prev 1999;8:533-539.
92. Meijers-Heijboer H, Brekelmans CTM, Menke-Pluymers M, Seynaeve C, et al. Use of Genet Test and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 2003;21:1675-1681.
93. Ropka ME, Wenzel J, Phillips EK, Siadaty M, et al. Uptake Rates for Breast Cancer Genet Test: A Systematic Review. Cancer Epidemiol Biomarkers Prev 2006;15:840-855.
94. Craufurd D, Dodge A, Kerzin-Storrar L, Harris R, et al. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 1989;2:603-605.
95. Lerman C, Hughes C, Trock BJ, Myers RE, et al. Genet Test in families with hereditary nonpolyposis colon cancer. JAMA 1999;281:1618-1622.
96. Quaid KA, Morris M. Reluctance to Undergo Predictive Testing - the Case of Huntington Disease. Am J Med Genet 1993;45:41-45.
97. Roberts JS, Barber M, Brown TM, Cupples LA, et al. Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genet Med 2004;6:197-203.